These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 33042993)

  • 1. Immune (Cell) Derived Exosome Mimetics (IDEM) as a Treatment for Ovarian Cancer.
    Pisano S; Pierini I; Gu J; Gazze A; Francis LW; Gonzalez D; Conlan RS; Corradetti B
    Front Cell Dev Biol; 2020; 8():553576. PubMed ID: 33042993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioinspired exosome-mimetic nanovesicles for targeted delivery of chemotherapeutics to malignant tumors.
    Jang SC; Kim OY; Yoon CM; Choi DS; Roh TY; Park J; Nilsson J; Lötvall J; Kim YK; Gho YS
    ACS Nano; 2013 Sep; 7(9):7698-710. PubMed ID: 24004438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage-derived exosome-mimetic hybrid vesicles for tumor targeted drug delivery.
    Rayamajhi S; Nguyen TDT; Marasini R; Aryal S
    Acta Biomater; 2019 Aug; 94():482-494. PubMed ID: 31129363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosomes From Human Cardiac Progenitor Cells for Therapeutic Applications: Development of a GMP-Grade Manufacturing Method.
    Andriolo G; Provasi E; Lo Cicero V; Brambilla A; Soncin S; Torre T; Milano G; Biemmi V; Vassalli G; Turchetto L; Barile L; Radrizzani M
    Front Physiol; 2018; 9():1169. PubMed ID: 30197601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-free synthesis of connexin 43-integrated exosome-mimetic nanoparticles for siRNA delivery.
    Lu M; Zhao X; Xing H; Liu H; Lang L; Yang T; Xun Z; Wang D; Ding P
    Acta Biomater; 2019 Sep; 96():517-536. PubMed ID: 31284098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosomes Derived From Natural Killer Cells Exert Therapeutic Effect in Melanoma.
    Zhu L; Kalimuthu S; Gangadaran P; Oh JM; Lee HW; Baek SH; Jeong SY; Lee SW; Lee J; Ahn BC
    Theranostics; 2017; 7(10):2732-2745. PubMed ID: 28819459
    [No Abstract]   [Full Text] [Related]  

  • 7. Ultrasound-mediated augmented exosome release from astrocytes alleviates amyloid-β-induced neurotoxicity.
    Deng Z; Wang J; Xiao Y; Li F; Niu L; Liu X; Meng L; Zheng H
    Theranostics; 2021; 11(9):4351-4362. PubMed ID: 33754065
    [No Abstract]   [Full Text] [Related]  

  • 8. Targeting and Therapy of Glioblastoma in a Mouse Model Using Exosomes Derived From Natural Killer Cells.
    Zhu L; Oh JM; Gangadaran P; Kalimuthu S; Baek SH; Jeong SY; Lee SW; Lee J; Ahn BC
    Front Immunol; 2018; 9():824. PubMed ID: 29740437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Nanodrug Consisting Of Doxorubicin And Exosome Derived From Mesenchymal Stem Cells For Osteosarcoma Treatment In Vitro.
    Wei H; Chen J; Wang S; Fu F; Zhu X; Wu C; Liu Z; Zhong G; Lin J
    Int J Nanomedicine; 2019; 14():8603-8610. PubMed ID: 31802872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel alternatives to extracellular vesicle-based immunotherapy - exosome mimetics derived from natural killer cells.
    Zhu L; Gangadaran P; Kalimuthu S; Oh JM; Baek SH; Jeong SY; Lee SW; Lee J; Ahn BC
    Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S166-S179. PubMed ID: 30092165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Glioma Cells' Proliferation by Doxorubicin-Loaded Exosomes via Microfluidics.
    Thakur A; Sidu RK; Zou H; Alam MK; Yang M; Lee Y
    Int J Nanomedicine; 2020; 15():8331-8343. PubMed ID: 33149579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted Delivery of Exosomes Armed with Anti-Cancer Therapeutics.
    Choi H; Yim H; Park C; Ahn SH; Ahn Y; Lee A; Yang H; Choi C
    Membranes (Basel); 2022 Jan; 12(1):. PubMed ID: 35054611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted doxorubicin-loaded mesenchymal stem cells-derived exosomes as a versatile platform for fighting against colorectal cancer.
    Bagheri E; Abnous K; Farzad SA; Taghdisi SM; Ramezani M; Alibolandi M
    Life Sci; 2020 Nov; 261():118369. PubMed ID: 32882265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Palladium Nanoparticle-Induced Oxidative Stress, Endoplasmic Reticulum Stress, Apoptosis, and Immunomodulation Enhance the Biogenesis and Release of Exosome in Human Leukemia Monocytic Cells (THP-1).
    Gurunathan S; Kang MH; Jeyaraj M; Kim JH
    Int J Nanomedicine; 2021; 16():2849-2877. PubMed ID: 33883895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian cancer cell invasiveness is associated with discordant exosomal sequestration of Let-7 miRNA and miR-200.
    Kobayashi M; Salomon C; Tapia J; Illanes SE; Mitchell MD; Rice GE
    J Transl Med; 2014 Jan; 12():4. PubMed ID: 24393345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Graphene Oxide Enhances Biogenesis and Release of Exosomes in Human Ovarian Cancer Cells.
    Gurunathan S; Kim JH
    Int J Nanomedicine; 2022; 17():5697-5731. PubMed ID: 36466784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-Derived Nanovesicles as Exosome-Mimetics for Drug Delivery Purposes: Uses and Recommendations.
    Ou YH; Zou S; Goh WJ; Wang JW; Wacker M; Czarny B; Pastorin G
    Methods Mol Biol; 2021; 2211():147-170. PubMed ID: 33336276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microvesicle- and exosome-mediated drug delivery enhances the cytotoxicity of Paclitaxel in autologous prostate cancer cells.
    Saari H; Lázaro-Ibáñez E; Viitala T; Vuorimaa-Laukkanen E; Siljander P; Yliperttula M
    J Control Release; 2015 Dec; 220(Pt B):727-37. PubMed ID: 26390807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional exosome-mediated co-delivery of doxorubicin and hydrophobically modified microRNA 159 for triple-negative breast cancer therapy.
    Gong C; Tian J; Wang Z; Gao Y; Wu X; Ding X; Qiang L; Li G; Han Z; Yuan Y; Gao S
    J Nanobiotechnology; 2019 Sep; 17(1):93. PubMed ID: 31481080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current Knowledge and Future Perspectives of Exosomes as Nanocarriers in Diagnosis and Treatment of Diseases.
    Zou Z; Li H; Xu G; Hu Y; Zhang W; Tian K
    Int J Nanomedicine; 2023; 18():4751-4778. PubMed ID: 37635911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.